163 related articles for article (PubMed ID: 19164263)
41. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
42. "Icodextrin alone" for initiation of peritoneal dialysis.
Jeloka TK
Perit Dial Int; 2008; 28(5):563-4. PubMed ID: 18708559
[No Abstract] [Full Text] [Related]
43. Glucose monitoring for diabetic patients using icodextrin.
Wang R; Skoufos L; Martis L
Perit Dial Int; 2004; 24(3):296-7. PubMed ID: 15185782
[No Abstract] [Full Text] [Related]
44. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.
Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC;
Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118
[TBL] [Abstract][Full Text] [Related]
45. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients.
Cho KH; Do JY; Park JW; Yoon KW
Nephrol Dial Transplant; 2010 Feb; 25(2):593-9. PubMed ID: 19767632
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
47. Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients.
Lin W; Chen YC; Wu MS; Hsu HJ; Sun CY; Lin YK; Wu IW
Ren Fail; 2009; 31(2):98-105. PubMed ID: 19212905
[TBL] [Abstract][Full Text] [Related]
48. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
49. Are current peritoneal dialysis solutions adequate for pediatric use?
Verrina EE; Cannavò R; Schaefer B; Schmitt CP
Contrib Nephrol; 2012; 178():16-22. PubMed ID: 22652710
[TBL] [Abstract][Full Text] [Related]
50. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.
Gotloib L; Wajsbrot V; Shostak A
Nephron; 2002 Sep; 92(1):142-55. PubMed ID: 12187097
[TBL] [Abstract][Full Text] [Related]
51. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
53. Icodextrin metabolites in peritoneal dialysis.
García-López E; Lindholm B
Perit Dial Int; 2009; 29(4):370-6. PubMed ID: 19602601
[No Abstract] [Full Text] [Related]
54. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
55. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
[TBL] [Abstract][Full Text] [Related]
56. Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine.
Gotloib L; Wajsbrot V; Shostak A
Free Radic Biol Med; 2003 Feb; 34(4):419-28. PubMed ID: 12566067
[TBL] [Abstract][Full Text] [Related]
57. Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions.
Hwang JC; Wang HY; Wang CT; Chen HC
J Nephrol; 2006; 19(6):758-63. PubMed ID: 17173249
[TBL] [Abstract][Full Text] [Related]
58. Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells.
Lin X; Amore A; Loiacono E; Balegno S; Manniello D; Peruzzi L; Camilla R; Minieri V; Daprà V; Qian J; Coppo R
J Nephrol; 2009; 22(1):117-22. PubMed ID: 19229826
[TBL] [Abstract][Full Text] [Related]
59. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
Dawnay AB; Millar DJ
Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
[TBL] [Abstract][Full Text] [Related]
60. Sodium sieving in children.
Rusthoven E; Krediet RT; Willems HL; Monnens LA; Schröder CH
Perit Dial Int; 2005 Feb; 25 Suppl 3():S141-2. PubMed ID: 16048281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
